NCT00720031
- Conditions
- Immunotherapy, Melanoma, Neoplasms, +10 more
- Locations
-
- Nantes University Hopspital Nantes, Pays de la Loire Region, France
Clinical trial condition
Immunotherapy
Explore clinical trials studying Immunotherapy. Study availability and eligibility vary by location and protocol.
216 public trials
103 recruiting studies
Immunotherapy trial results
NCT00540150
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +7 more
- Locations
-
- Goethe University, Department of Pulmonology Frankfurt am Main, Hesse, Germany
Active, Not Recruiting
Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer
NCT06215677
- Conditions
- Colon Cancer, Colonic Diseases, Colonic Neoplasms, +12 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, China
Active, Not Recruiting
Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment
NCT04706598
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Immunotherapy, +9 more
- Locations
-
- Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
- Shanghai Tenth People's Hospital,Shanghai Tong Ji University School of Medicine Shanghai, Shanghai Municipality, China
- Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Active, Not Recruiting
A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma
NCT07010120
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +10 more
- Locations
-
- Department of Radiation Oncology Chengdu, Sichuan, China
Active, Not Recruiting
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)
NCT05520099
- Conditions
- Adenocarcinoma, Bladder Cancer, Bronchial Neoplasms, +72 more
- Locations
-
- CARTI Cancer Center Little Rock, Arkansas, United States
- Salinas Valley Memorial Healthcare System Salinas, California, United States
- AdventHealth Orlando Orlando, Florida, United States
- Memorial Health System Pembroke Pines, Florida, United States
Active, Not Recruiting
Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)
NCT05621707
- Conditions
- Chemotherapy, Concurrent Chemoradiotherapy, Digestive System Diseases, +10 more
- Locations
-
- Shanghai Chest Hospital Shanghai, Shanghai Municipality, China
Active, Not Recruiting
Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial
NCT06128863
- Conditions
- Immunotherapy, Neoadjuvant, Neoplasms, +5 more
- Locations
-
- Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland
Active, Not Recruiting
Camrelizumab in Combination With Radiotherapy for Neoadjuvant Esophageal Carcinoma.
NCT05176002
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +9 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
Active, Not Recruiting
Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer
NCT07230080
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Nanfang Hosptial Guangzhou, China